We are live on ! Find out more
SCS

Syquant Capital SAS Portfolio holdings

AUM $447M
1-Year Est. Return 13.04%
This Fund
S&P 500
This Quarter Est. Return
+15.97%
1 Year Est. Return
+13.04%
3 Year Est. Return
+175.6%
5 Year Est. Return
+350.63%
10 Year Est. Return
–
AUM
$302M
AUM Growth
+$161M
Cap. Flow
+$138M
Cap. Flow %
45.6%
Top 10 Hldgs %
98.44%
Holding
25
New
10
Increased
2
Reduced
–
Closed
11

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$83.7M
2
K
Kellanova
K
+$51.7M
3
TGI
Triumph Group
TGI
+$14.5M
4
WBA
Walgreens Boots Alliance
WBA
+$14.3M
5
DNB
Dun & Bradstreet
DNB
+$11.2M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$35.1M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$18.5M
3
DESP
Despegar.com
DESP
+$8.41M
4
PLYA
Playa Hotels & Resorts
PLYA
+$4.1M
5
HEES
H&E Equipment Services
HEES
+$2.65M

Sector Composition

Rank Sector Weight
1 Healthcare 43.44%
2 Consumer Staples 30.16%
3 Financials 11.77%
4 Industrials 4.85%
5 Technology 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$103M 34.24%
+805,603
New +$83.7M
K
2
DELISTED
Kellanova
K
$90.9M 30.16%
1,143,568
+632,168
+124% +$51.7M
ESGR
3
DELISTED
Enstar Group
ESGR
$24.2M 8.01%
71,807
– –
WBA
4
DELISTED
Walgreens Boots Alliance
WBA
$14.7M 4.89%
+1,284,217
New +$14.3M
TGI
5
DELISTED
Triumph Group
TGI
$14.6M 4.85%
+568,177
New +$14.5M
JNPR
6
DELISTED
Juniper Networks
JNPR
$12.1M 4.01%
+302,620
New +$10.8M
SWTX
7
DELISTED
SpringWorks Therapeutics
SWTX
$11.6M 3.85%
+247,000
New +$11M
SKX
8
DELISTED
Skechers
SKX
$11.6M 3.85%
+183,934
New +$10.6M
DNB
9
DELISTED
Dun & Bradstreet
DNB
$11.4M 3.76%
+1,248,800
New +$11.2M
APP icon
10
Applovin
APP
$143B
$2.51M 0.83%
7,180
+251
+4% +$81.4K
CON
11
Concentra Group Holdings
CON
$4.04B
$1.4M 0.46%
+67,800
New +$1.45M
PACHU
12
Pioneer Acquisition I Corp Units
PACHU
$1.1M 0.37%
+110,000
New +$1.1M
WENNU
13
Wen Acquisition Corp Unit
WENNU
$265K 0.09%
+25,000
New +$265K
COIN icon
14
Coinbase
COIN
$41.4B
– –
-5,398
Closed -$930K
DESP
15
DELISTED
Despegar.com
DESP
– –
-447,800
Closed -$8.41M
HEES
16
DELISTED
H&E Equipment Services
HEES
– –
-28,000
Closed -$2.65M
HOOD icon
17
Robinhood
HOOD
$89.7B
– –
-10,700
Closed -$445K
PLYA
18
DELISTED
Playa Hotels & Resorts
PLYA
– –
-307,458
Closed -$4.1M
RDDT icon
19
Reddit
RDDT
$34.9B
– –
-3,940
Closed -$413K
BECN
20
DELISTED
Beacon Roofing Supply, Inc.
BECN
– –
-149,581
Closed -$18.5M
AMPS
21
DELISTED
Altus Power
AMPS
– –
-255,000
Closed -$1.26M
PYCR
22
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
– –
-50,000
Closed -$1.12M
ITCI
23
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-266,228
Closed -$35.1M
DM
24
DELISTED
Desktop Metal, Inc.
DM
– –
-20,900
Closed -$103K

Similar funds

PT
Plimoth Trust Plymouth, Massachusetts $447M AUM 24.12% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $448M AUM 21.79% 1-Year Est. Return
PC
Peavine Capital Reno, Nevada $446M AUM 7.66% 1-Year Est. Return
AIS
American Investment Services Great Barrington, Massachusetts $448M AUM 21.7% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $446M AUM 13.55% 1-Year Est. Return
FTA
Financial & Tax Architects St Louis, Missouri $448M AUM 13.98% 1-Year Est. Return
GC
Guidance Capital Lousville, Kentucky $446M AUM 19.83% 1-Year Est. Return
POEH
Post Oak Energy Holdings Houston, Texas $449M AUM 53.94% 1-Year Est. Return

Syquant Capital SAS's Q2 2025 Portfolio in Review

As of Q2 2025, Syquant Capital SAS held 25 positions worth $302M, up 114% from $141M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Syquant Capital SAS deployed $138M of net new capital in Q2 2025, opening 10 new positions and adding to 2 existing holdings. Its largest new stake was Blueprint Medicines: 805,603 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the most notable exit was Intra-Cellular Therapies Inc., an estimated $35.1M sold.

  • Syquant Capital SAS's largest Q2 2025 buy was Blueprint Medicines: 805,603 shares worth $103M.
  • Syquant Capital SAS added most to Kellanova in Q2 2025, an estimated $51.7M increase.
  • Syquant Capital SAS fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $35.1M.
  • Syquant Capital SAS's ten largest holdings make up 98% of its $302M portfolio in Q2 2025.
  • Syquant Capital SAS opened 10 new positions and closed 11 in Q2 2025.
  • Syquant Capital SAS's portfolio value rose 114% quarter-over-quarter to $302M.

Based on Syquant Capital SAS's 13F filing for Q2 2025, filed 15 Jul 2025.